
HTH-01-091
CAS No. 2000209-42-5
HTH-01-091( HTH-01-091 | HTH 01-091 | HTH01-091 )
Catalog No. M13123 CAS No. 2000209-42-5
HTH-01-091 is a potent and selective, cell-permeable, ATP-competitive MELK inhibitor with biochemical IC50 of 10.5 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 745 | Get Quote |
![]() ![]() |
10MG | 1017 | Get Quote |
![]() ![]() |
25MG | 1431 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
500MG | 4410 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameHTH-01-091
-
NoteResearch use only, not for human use.
-
Brief DescriptionHTH-01-091 is a potent and selective, cell-permeable, ATP-competitive MELK inhibitor with biochemical IC50 of 10.5 nM.
-
DescriptionHTH-01-091 is a potent and selective, cell-permeable, ATP-competitive MELK inhibitor with biochemical IC50 of 10.5 nM; displays no significant activity for PIK3CA, mTOR, GSK3A and CDK7 (IC50>600 nM); exhibits substantially improved kinome selectivity in comparison with OTSSP167; induces MELK degradation, but demonstrates poor antiproliferative effects in basal-like breast cancer cell lines.
-
In VitroHTH-01-091 (1 μM) selectively inhibits 4% of the kinases over 90%. HTH-01-091 (0-10 μM, 1 h) is cell permeable and causes MELK degradation.HTH-01-091 (0-10 μM, 3 day) exhibits minor antiproliferative effects in breast cancer cells. Western Blot Analysis Cell Line:MDA-MB-468 cells Concentration:0, 0.1, 1.0, and 10 μM Incubation Time:1 h Result:Reduced MELK protein levels in MDA-MB-468 cells; Dose-dependently decreased MELK pull-down by streptavidin beads, demonstrating that the compound is cell permeable and binds to MELK in an ATP-competitive fashion. Had no effect on ERK1/2 pull-down, showing no binding affinity of HTH-01-091 to ERK1/2. Cell Proliferation Assay Cell Line:MDA-MB-468, BT-549, HCC70, ZR-75-1, MCF7, and T-47D cells Concentration:0, 0.001, 0.01, 0.1, 1.0, and 10 μM Incubation Time:3 day Result:Showed antiproliferative activities in a panel of breast cancer cell lines, including MDA-MB-468, BT-549, HCC70, ZR-75-1, MCF7, and T-47D cells, with IC50 values of 4.00 μM, 6.16 μM, 8.80 μM, >10 μM, 8.75 μM, and 3.87 μM, respectively.
-
In Vivo——
-
SynonymsHTH-01-091 | HTH 01-091 | HTH01-091
-
PathwayPI3K/Akt/mTOR signaling
-
TargetMELK
-
RecptorMELK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2000209-42-5
-
Formula Weight499.436
-
Molecular FormulaC26H28Cl2N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N([C@H]2CC[C@H](CN(C)C)CC2)C3=C(CN1)C=NC4=CC=C(C5=CC(Cl)=C(O)C(Cl)=C5)C=C34
-
Chemical Name9-(3,5-dichloro-4-hydroxyphenyl)-1-((1r,4r)-4-((dimethylamino)methyl)cyclohexyl)-3,4-dihydropyrimido[5,4-c]quinolin-2(1H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang HT, et al. Elife. 2017 Sep 19;6. pii: e26693.
molnova catalog



related products
-
Kinase inhibitor C1
A potent small molecule inhibitor of MELK kinase activity with IC50 of 42 nM.
-
MELK-T1
A novel, cell-permeable, potent and selective inhibitor of MELK kinase domain with IC50 of 37 nM.
-
NVP-MELK8a hydrochlo...
NVP-MELK8a hydrochloride (MELK8a hydrochloride)?is a novel potent, and selective MELK inhibitor with IC50 of 2 nM.